Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HFD2
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 18 |
GO:0043167 | ion binding | 2 | 18 |
GO:0043169 | cation binding | 3 | 18 |
GO:0046872 | metal ion binding | 4 | 18 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 90 | 94 | PF00082 | 0.284 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.549 |
DOC_MAPK_gen_1 | 68 | 77 | PF00069 | 0.478 |
DOC_PP4_MxPP_1 | 11 | 14 | PF00568 | 0.441 |
DOC_USP7_MATH_1 | 44 | 48 | PF00917 | 0.505 |
DOC_USP7_UBL2_3 | 70 | 74 | PF12436 | 0.446 |
LIG_14-3-3_CanoR_1 | 101 | 107 | PF00244 | 0.651 |
LIG_APCC_ABBA_1 | 75 | 80 | PF00400 | 0.291 |
LIG_APCC_ABBAyCdc20_2 | 74 | 80 | PF00400 | 0.291 |
LIG_FHA_2 | 41 | 47 | PF00498 | 0.534 |
LIG_Integrin_isoDGR_2 | 51 | 53 | PF01839 | 0.635 |
LIG_LIR_Apic_2 | 35 | 41 | PF02991 | 0.304 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.523 |
LIG_MYND_1 | 10 | 14 | PF01753 | 0.293 |
LIG_Pex14_1 | 16 | 20 | PF04695 | 0.318 |
LIG_SH2_GRB2like | 48 | 51 | PF00017 | 0.527 |
LIG_SH2_SRC | 28 | 31 | PF00017 | 0.334 |
LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.403 |
LIG_SH2_STAT3 | 5 | 8 | PF00017 | 0.520 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.326 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.546 |
LIG_SH3_3 | 7 | 13 | PF00018 | 0.516 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.527 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.635 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.366 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.532 |
MOD_GSK3_1 | 66 | 73 | PF00069 | 0.534 |
MOD_PIKK_1 | 102 | 108 | PF00454 | 0.602 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.379 |
MOD_SUMO_rev_2 | 19 | 26 | PF00179 | 0.406 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4E5 | Leptomonas seymouri | 83% | 98% |
A0A0N0P975 | Leptomonas seymouri | 50% | 90% |
A0A0S4IT37 | Bodo saltans | 45% | 80% |
A0A1X0NLL7 | Trypanosomatidae | 57% | 88% |
A0A3R7NZE2 | Trypanosoma rangeli | 55% | 80% |
A0A3S7X0B7 | Leishmania donovani | 96% | 76% |
A0A3S7X5L3 | Leishmania donovani | 46% | 89% |
A4HKG1 | Leishmania braziliensis | 43% | 91% |
A4I363 | Leishmania infantum | 96% | 76% |
A4I7Y9 | Leishmania infantum | 46% | 89% |
C9ZKV1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 88% |
D0AA56 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 83% |
E9ACZ0 | Leishmania major | 94% | 100% |
E9AYR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9B2V0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 47% | 89% |
Q4Q5A6 | Leishmania major | 48% | 100% |